Thrombosis and cancer

miRNA and its role in cancer-associated thrombosis

Cancer-associated thrombosis (CAT) is one of the leading causes of non-cancer-related deaths in patients with cancer...

Incidental venous thromboembolism (VTE) refers to any case of deep venous thromboembolism or pulmonary embolism (PE)...

Advances in medicine and the possibility of keeping multiple diseases under control via medication have increased the...

Patients with cancer are at high risk of venous thromboembolism (VTE) recurrence and major bleeding (1). Most...

The clinical issues and the main consequences of venous thromboembolism (VTE) in patients with cancer are nowadays well...

Venous thromboembolism (VTE) is a frequent complication and the second leading cause of death in cancer patients....

What is the physician perception and common practice in treatment of venous thromboembolism (VTE) in cancer patients?...

Value and limitations of low-molecular-weight heparins Following the demonstration that vitamin K antagonists (VKA) are...

It is well known that patients with cancer are at high risk of venous thromboembolism (VTE), especially when initiating...

Venous thromboembolism (VTE) is a recurrent risk factor in cancer patients. In particular, patients with hematologic...